General Thoracic
Carl Gay, MD, PhD
Assistant Professor
MD Anderson Cancer Center
Houston, Texas, United States
Disclosure(s): Abdera: Advisory Board (Terminated, February 23, 2024); ACHL: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Amgen Inc.: Advisory Board (Terminated, September 1, 2024); Astra Zeneca: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Catalyst: Advisory Board (Terminated), Consultant (Terminated); CEA: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo: Advisory Board (Terminated), Speaker (Terminated); Dava Oncology: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); G1 Therapeutics: Advisory Board (Terminated); IDEOlogy Health: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Insights Driven Research: Consultant (Terminated); Jazz Pharmaceuticals: Advisory Board (Ongoing), Consultant (Ongoing); MJH: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); OncoHost: Advisory Board (Terminated); PEERView: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)